Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Bioline EPIK Quantification, Amplification Kits


Bioline, a Meridian Bioscience company, this week launched the EPIK Quantification and EPIK Amplification kits.

The new kits were developed to meet the needs of researchers using PCR and real-time PCR in epigenetic research. They are based on the company's MyTaq and SensiFAST polymerases and a novel EPIKORE buffer system, formulated to overcome the challenges associated with bisulfite-modified DNA templates. The company said that they kits' speed, specificity, and reliability make them well-suited to high-throughput epigenetic studies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.